{"id":"https://openalex.org/W2167384366","doi":"https://doi.org/10.3109/00498259109039494","title":"Nonlinear first-pass metabolism of nifedipine in healthy subjects","display_name":"Nonlinear first-pass metabolism of nifedipine in healthy subjects","alternate_titles":[],"publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W2167384366","doi":"https://doi.org/10.3109/00498259109039494","mag":"2167384366","pmid":"https://pubmed.ncbi.nlm.nih.gov/1897253"},"language":"en","primary_location":{"id":"doi:10.3109/00498259109039494","doi":"https://doi.org/10.3109/00498259109039494","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00498259109039494","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2167384366"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. H. M. Schellens","raw_affiliation_strings":["Division of Pharmacology, University of Leiden, The Netherlands","Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, University of Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337"]},{"raw_affiliation_string":"Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078673205","display_name":"Ingrid M.M. van Haelst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"I. M. M. Van Haelst","raw_affiliation_strings":["Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109162124","display_name":"James Brian. Houston","orcid":"https://orcid.org/0000-0002-9322-0533","observed_orcids":["https://orcid.org/0000-0002-9322-0533"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J. B. Houston","raw_affiliation_strings":["Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111780494","display_name":"Douwe D. Breimer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"D. D. Breimer","raw_affiliation_strings":["Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Bio-Pharmaceutical Sciences, Division of Pharmacology, University of Leiden, PO Box 9503, 2300, RA Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I121797337"],"apc_list":null,"apc_paid":null,"fwci":1.6715,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.78546051,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"21","issue":"4","first_page":"547","last_page":"555"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":1.0},{"id":"https://openalex.org/keywords/first-pass-metabolism","display_name":"first-pass metabolism","score":0.8619999885559082},{"id":"https://openalex.org/keywords/nonlinear-pharmacokinetics","display_name":"nonlinear pharmacokinetics","score":0.9010000228881836},{"id":"https://openalex.org/keywords/ester-hydrolysis","display_name":"ester hydrolysis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/urinary-excretion","display_name":"urinary excretion","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.7776496410369873},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.6290872693061829},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.4361609220504761},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4038405120372772},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3792017102241516},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37494468688964844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3748686909675598},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3563233017921448},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3443233370780945},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.17226934432983398}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/00498259109039494","doi":"https://doi.org/10.3109/00498259109039494","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00498259109039494","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},{"id":"pmid:1897253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1897253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica; the fate of foreign compounds in biological systems","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W40366074","https://openalex.org/W1829225133","https://openalex.org/W1970059344","https://openalex.org/W1999443762","https://openalex.org/W2008738913","https://openalex.org/W2011910735","https://openalex.org/W2018429921","https://openalex.org/W2027508370","https://openalex.org/W2051364778","https://openalex.org/W2054811864","https://openalex.org/W2071092830","https://openalex.org/W2083836116","https://openalex.org/W2092869459","https://openalex.org/W2100104377","https://openalex.org/W4236362842","https://openalex.org/W4241291456"],"related_works":["https://openalex.org/W2054811864","https://openalex.org/W2112085584","https://openalex.org/W1987469331","https://openalex.org/W2100104377","https://openalex.org/W763007482","https://openalex.org/W2025420042","https://openalex.org/W652434746","https://openalex.org/W2159694382","https://openalex.org/W2008712048","https://openalex.org/W1978167849"],"abstract_inverted_index":{"1.":[0],"A":[1],"dose-range":[2],"study":[3],"was":[4,49,74,111,142],"carried":[5],"out":[6],"with":[7,103],"nifedipine":[8],"(NF)":[9],"in":[10,22],"11":[11],"healthy":[12],"subjects,":[13],"who":[14],"received":[15],"orally":[16],"5,":[17],"10":[18,54,80,116],"and":[19,25,60,81,122],"20":[20,26,62,82,124],"mg":[21,27,47,55,63,83,90,109,117,125],"capsules":[23],"(cap)":[24,48,56,64,110,118,126],"as":[28],"slow-release":[29],"tablet.":[30],"2.":[31],"The":[32,69,93,132],"dose-normalized":[33,94],"area":[34],"under":[35],"the":[36,72,97,148,163],"curve":[37],"(AUC)":[38],"of":[39,45,53,61,71,79,96,107,115,123,134,147,165,170],"NF":[40,155],"showed":[41],"significant":[42],"nonlinearity:":[43],"AUC":[44,70,95,106],"5":[46,89,108],"312":[50],"+/-":[51,58,66,113,120,128],"179,":[52],"357":[57],"186":[59],"424":[65],"174":[67],"(ng.h/ml).":[68,130],"tablet":[73],"significantly":[75,101],"lower":[76],"than":[77],"that":[78,154,169],"(cap),":[84],"but":[85,167],"not":[86,143,168],"different":[87,144],"from":[88],"(cap).":[91],"3.":[92],"pyridine":[98],"metabolite":[99],"(M-0)":[100],"decreased":[102],"increasing":[104],"dose:":[105],"244":[112],"88,":[114],"194":[119],"96":[121],"120":[127],"37":[129],"4.":[131],"excretion":[133],"M-I":[135],"(which":[136],"is":[137,152],"ester-hydrolysed":[138],"M-0)":[139],"into":[140],"urine":[141],"for":[145],"any":[146],"doses.":[149],"5.":[150],"It":[151],"concluded":[153],"exhibits":[156],"nonlinear":[157],"first-pass":[158],"metabolism,":[159],"which":[160],"concomitantly":[161],"affects":[162],"formation":[164],"M-0,":[166],"M-I.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2167384366","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
